Status:
NOT_YET_RECRUITING
Proactive Costs of Care Study
Lead Sponsor:
Cedars-Sinai Medical Center
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Financial Burden
Financial Toxicity
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The Proactive Costs of Care intervention is an educational intervention designed to help patients deal with the cost of cancer care. The main goal of this trial is to evaluate whether the Proactive Co...
Detailed Description
The Proactive Costs of Care (PCOC) study aims to assess whether the Proactive Costs of Care intervention can be successfully delivered to cancer patients and help them deal with the costs of cancer ca...
Eligibility Criteria
Inclusion
- Individuals 18 years old or older are included.
- Individuals diagnosed with gynecologic cancer
- On active systemic therapy within 30 days of enrollment
- Receiving treatment at Cedars-Sinai Medical Center
- Can speak, read, and understand English
Exclusion
- Any patients whose records are flagged "break the glass" or "research opt out."
- Cannot speak, read, or understand English
- Not willing to participate in the intervention or complete surveys
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT07217262
Start Date
November 1 2025
End Date
April 1 2027
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048